Yu, Y. (2023). 442-J Anti-AXL CAR-NK cell immunotherapy to target BRAF inhibitor drug-resistant and metastatic melanoma. BMJ Publishing Group.
Chicago Style (17th ed.) CitationYu, Yanlin. 442-J Anti-AXL CAR-NK Cell Immunotherapy to Target BRAF Inhibitor Drug-resistant and Metastatic Melanoma. BMJ Publishing Group, 2023.
MLA (9th ed.) CitationYu, Yanlin. 442-J Anti-AXL CAR-NK Cell Immunotherapy to Target BRAF Inhibitor Drug-resistant and Metastatic Melanoma. BMJ Publishing Group, 2023.
Warning: These citations may not always be 100% accurate.